Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line
Article excerpt
In this article Humana on Wednesday reported second-quarter results that topped estimates, as the health insurer's spending on medical services came in line with expectations. The company also maintained its 2026 adjusted profit outlook of at least $9 per share. The earnings beat was driven by strength across Humana's insurance business and CenterWell healthcare services unit, Humana CFO Celeste Mellet said in an interview. She said medical and pharmacy cost trends tracked in line with Humana's expectations across new and existing members. The company saw "slight favorability" in medical costs in the inpatient space, particularly among members receiving care from value-based providers, she added. Still, in a Wednesday note, Cantor Fitzgerald analysts called the unchanged profit outlook a "disappointment" after recent earnings beats and guidance raises seen by other insurers overseeing privately run Medicare Advantage plans. Investors have been ratcheting up their expectations for the industry as some companies hike their outlooks and get a better handle on rising medical costs in those plans – an issue that has been dogging the broader sector for more than two years. Shares of Humana fell more than 4% in premarket trading despite the solid quarter. The company is one of the largest Medicare Advantage providers serving people aged 65 and older as well as people with...
Keep reading with a free account
The rest of this article, and every signal for Humana, is in your free account.
Extracted from this sentence
Revenue climbed to $40.87 billion from $32.39 billion in the prior-year quarter.
